Discover your next big idea for life sciences at PACK EXPO Las Vegas
Experience a breakthrough in life sciences packaging—explore solutions from 2,300 suppliers spanning all industries, all in one place this September

Animal health medications benefit from serialization technology

Serialization technology protects global pharmaceutical and biotech maker protect its flea-and-tick medications.

Serialization technology protects global pharmaceutical and biotech maker protect its flea-and-tick medications.
Serialization technology protects global pharmaceutical and biotech maker protect its flea-and-tick medications.

With a vision to ensure safety and sanctity of their animal health medications, a global pharmaceutical and biotech manufacturer has selected and implemented Xyntek and Antares serialization technology to protect their animal health brand.

The product, which was serialized and aggregated by the Xyntek and Antares technology, is an animal medication used to prevent fleas and ticks in household pets.

The technology features the Antares Tracking System (ATS) software platform and pre-engineered Print & Check modules. The technology not only serializes at the smallest unit of sale, but also provides several layers of aggregation and serialization at the bundle/tray, and case.

The serialization technology enables the client to efficiently and reliably track and trace their animal care product through the entire supply chain and ensures that only authentic and quality product will reach its consumers. To date, there have been a handful of instances where diverged or expired product has been identified in the market place. Using the Xyntek and Antares technology, the client is able to track where these packages originated from and where they have shipped to, and as a result remove bad and diverted products from the shelves, and protect their consumers and brand image.

According to Mac Hashemian, Xyntek CEO,"Product Serialization is the first step to ensure compliance with the Drug Quality and Security Act (DQSA) and other existing and emerging global track-and-trace regulations that require product visibility and traceability throughout the prescription drug supply chain. However, these technologies have value outside of just complying with the regulatory requirements. Added benefits such as recall management, returns management, diverted products, etc., bring value to our clients’ products that should not be restricted to just prescription pharmaceuticals. A lot of return on investments can be gained by applying the same technologies for non-prescription products, including animal healthcare products and consumer healthcare products that are not currently under any federal regulation for track and trace. “

Pharmaceutical Innovations Report
Discover the latest breakthrough packaging technologies shaping the pharmaceutical sector. This report dives into cutting-edge innovations, from smart containers that enhance patient safety to eco-friendly materials poised to transform the industry’s sustainability practices. All from PACK EXPO. Learn how forward-thinking strategies are driving efficiency and redefining what’s possible in pharma packaging.
Learn More
Pharmaceutical Innovations Report
Medical Device Innovations Report
Cutting-edge packaging technologies are transforming the medical device sector in PMMI’s “Innovation in Medical Device” report, featuring advanced materials, smart solutions, and evolving regulations. Editors share insights from nearly 300 PACK EXPO booth visits—each product deemed new and truly innovative—alongside video demonstrations of the equipment and materials on display.
Learn More
Medical Device Innovations Report